Fabry disease: overall effects of agalsidase alfa treatment.
Beck M, Ricci R, Widmer U, Dehout F, de Lorenzo AG, Kampmann C, Linhart A, Sunder-Plassmann G, Houge G, Ramaswami U, Gal A, Mehta A.
Beck M, et al. Among authors: widmer u.
Eur J Clin Invest. 2004 Dec;34(12):838-44. doi: 10.1111/j.1365-2362.2004.01424.x.
Eur J Clin Invest. 2004.
PMID: 15606727
Clinical Trial.